Company Profile



Barcelona, Cataluña, Spain

Founded Year




Operating Status


Social Media


Javier de Oca
Co-Founder, CEO

Gabriel Maeztu
Co-Founder, CTO

Álvaro Abella Bascarán
Co-Founder, CSO


IOMED, a pioneering medical technology company, is transforming the landscape of medical research through its innovative use of artificial intelligence (AI) and data extraction techniques. Leveraging cutting-edge technologies, IOMED aims to accelerate the discovery of medical insights by seamlessly extracting structured data from unstructured clinical records.

Traditional medical research often relies on manual data extraction from patient records, which can be time-consuming and prone to errors. IOMED's groundbreaking technology addresses this challenge by harnessing the power of AI to automatically extract structured data from unstructured clinical records.

By employing advanced natural language processing (NLP) algorithms, IOMED can identify key medical concepts, such as diagnoses, treatments, and patient demographics, with remarkable accuracy.

At the heart of IOMED's transformative technology lies their powerful platform. This robust system seamlessly integrates with existing electronic health record (EHR) systems, allowing healthcare institutions to leverage the vast amount of data available within their own records.

By employing machine learning algorithms, the platform continually refines its understanding of medical concepts, ensuring high-quality data extraction over time. This wealth of structured data can then be used by researchers to generate actionable insights, driving advancements in medical knowledge and patient care.

By automating the extraction of structured data, IOMED significantly reduces the time and effort required to conduct medical research studies. Researchers can now swiftly access comprehensive datasets, enabling them to identify patterns, trends, and correlations that were previously buried within unstructured clinical records. The speed and efficiency offered by IOMED's technology have the potential to expedite medical breakthroughs, improve treatment protocols, and ultimately enhance patient outcomes.

IOMED's impact extends beyond traditional medical research. Their technology also has the potential to revolutionize clinical trials and real-world evidence studies. By swiftly extracting structured data from patient records, the platform empowers researchers to identify eligible patient populations, design more targeted trials, and gain deeper insights into treatment efficacy and safety.

This paradigm shift can streamline the drug development process, ultimately bringing innovative therapies to market faster while ensuring their effectiveness in real-world scenarios.

Recognizing the importance of data privacy and security in the healthcare domain, IOMED has implemented stringent measures to safeguard patient information. The platform adheres to industry-standard encryption protocols and operates under strict compliance with data protection regulations, such as HIPAA and GDPR. By prioritizing data privacy, IOMED ensures that healthcare institutions and patients can confidently leverage their technology to drive medical advancements.

As the technology continues to evolve, IOMED envisions a future where data-driven discoveries shape personalized medicine, improving patient outcomes and transforming the landscape of healthcare worldwide.


Interview Javier de Oca

Our CEO Javier de Oca participated in the INFORSALUD event organized by SEIS. The COMSALUD team had the opportunity to ask him some questions about the tools developed by IOMED and the solutions they provide to the healthcare sector.

Similar Companies

About Us

futureTEKnow is a global database of emerging technology companies. Discover the latest disruptors and innovators in the field.



Trending Today